Ethic Inc. Sells 9,269 Shares of Genpact Limited (NYSE:G)

Ethic Inc. trimmed its position in shares of Genpact Limited (NYSE:G - Free Report) by 23.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 29,652 shares of the business services provider's stock after selling 9,269 shares during the period. Ethic Inc.'s holdings in Genpact were worth $1,274,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in G. Coppell Advisory Solutions LLC increased its position in Genpact by 529.5% during the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after purchasing an additional 503 shares during the last quarter. SRH Advisors LLC bought a new position in shares of Genpact during the 4th quarter valued at about $26,000. Atlas Capital Advisors Inc. increased its stake in Genpact by 55.8% in the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after purchasing an additional 216 shares in the last quarter. Manchester Capital Management LLC purchased a new stake in shares of Genpact during the 4th quarter worth about $38,000. Finally, GeoWealth Management LLC grew its position in shares of Genpact by 199.0% in the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after purchasing an additional 583 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.

Genpact Stock Performance

G traded down $0.24 on Monday, reaching $43.96. The stock had a trading volume of 138,999 shares, compared to its average volume of 1,591,782. Genpact Limited has a 12-month low of $30.38 and a 12-month high of $56.76. The company has a market cap of $7.69 billion, a P/E ratio of 15.48, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. The business's 50-day moving average price is $48.02 and its two-hundred day moving average price is $47.26. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.

Genpact (NYSE:G - Get Free Report) last released its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The firm had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. During the same period last year, the business posted $0.73 earnings per share. Genpact's revenue was up 7.4% compared to the same quarter last year. Sell-side analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Robert W. Baird lowered their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Needham & Company LLC lowered their price target on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, May 8th. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and raised their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Mizuho boosted their target price on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Finally, Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Genpact presently has an average rating of "Hold" and a consensus target price of $50.71.

Insiders Place Their Bets

In related news, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. This represents a 4.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Nicholas C. Gangestad bought 2,000 shares of the business's stock in a transaction on Tuesday, May 13th. The shares were acquired at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the transaction, the director now owns 2,000 shares in the company, valued at approximately $87,940. This trade represents a ∞ increase in their position. The disclosure for this purchase can be found here. 3.07% of the stock is owned by corporate insiders.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.